Meeting
2023 ASCO Annual Meeting
Comprehensive nationwide study on the prescription of experimental anticancer therapies for compassionate use in children and adolescents in France.
Authors
Pablo Berlanga
Gustave Roussy Cancer Campus, Villejuif, France
Pablo Berlanga , Liora Brunel , Isabelle Aerts , Lee Aymar Ndounga-Diakou , Marie Gadeyne , Nadège Corradini , Stephane Ducassou , Marion Strullu , Emilie De Carli , Nicolas André , Natacha Entz-Werle , Sandra Raimbault , Dominique Plantaz , Samuel Abbou , Marianne Roumy , Marjolaine Renouard , Virginie Gandemer , Salim Laghouati , Isabelle Yoldjian , Gilles Vassal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10019)
DOI
10.1200/JCO.2023.41.16_suppl.10019
Abstract #
10019
Poster Bd #
325
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Mind the gap: Estimating the opportunity lost due to the gap between FDA and EMA cancer drug approvals.
First Author: Samantha Gage
Poster
2023 ASCO Quality Care Symposium
Potential out-of-pocket savings from hematology/oncology drugs for commercially insured patients via Mark Cuban Cost Plus Drug Company.
First Author: Jenny Jing Xiang
Poster
2023 ASCO Quality Care Symposium
Impact of the end of public health emergency oral dispensing flexibilities for at-risk patients in a community oncology practice.
First Author: Lalan S. Wilfong
Poster
2020 ASCO Virtual Scientific Program
Interim data: Phase I/IIa study of EGFR-targeted EDV nanocells carrying cytotoxic drug PNU-159682 (E-EDV-D682) with immunomodulatory adjuvant EDVs carrying α-galactosyl ceramide (EDV-GC) in patients with recurrent, metastatic pancreatic cancer.
First Author: Joanne Lundy